DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vepesid (Etoposide) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vepesid (Etoposide) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-05-14

Patient: 54 year old female, weighing 58.4 kg (128.5 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytosar-U
    Dosage: 3000 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-07

Vepesid
    Dosage: 65 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Solu-Medrol
    Dosage: 500 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Rituxan
    Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Abiplatin
    Dosage: 40 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Other drugs received by patient: Aloxi; Ultracet; Senokot; Norvasc; Chlorhexidine; Vitamin B6



Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-04-16

Patient: 54 year old female, weighing 58.0 kg (127.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: 577.5 mg, cyclic (day 1 of each 28 day cycle)
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Cisplatin
    Dosage: 40 mg qd
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-27

Methylprednisolone Acetate
    Dosage: 500 mg qd
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-27

Vepesid
    Dosage: 60 mg qd
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-27

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic (day 2 of each 28 day cycle)
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Cytosar-U
    Dosage: 3100 mg qd
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-31

Other drugs received by patient: Chlorhexidine GAR; Kytril; Metoclopramide Hydrochloride; Norvasc; Ultracet



Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-04-13

Patient: 54 year old female, weighing 58.0 kg (127.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiplatin
    Dosage: 40 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Vepesid
    Dosage: 65 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Solu-Medrol
    Dosage: 500 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Cytosar-U
    Dosage: 3000 mg, 1x/day
    Start date: 2012-03-07

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Rituximab
    Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Other drugs received by patient: Aloxi; Senokot; Vitamin B6; Norvasc; Ultracet; Chlorhexidine



Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-04-06

Patient: 54 year old female, weighing 58.4 kg (128.5 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiplatin
    Dosage: 40 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Cytosar-U
    Dosage: 3000 mg, 1x/day
    Start date: 2012-03-07

Rituximab
    Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Solu-Medrol
    Dosage: 500 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Vepesid
    Dosage: 65 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03

Other drugs received by patient: Aloxi; Vitamin B6; Ultracet; Chlorhexidine; Norvasc; Senokot



Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-04-05

Patient: 54 year old female, weighing 58.4 kg (128.5 pounds)

Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, non-Hodgkin's Lymphoma Recurrent

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytosar-U
    Dosage: 3000 mg, 1x/day
    Start date: 2012-03-07
    End date: 2012-03-07

Vepesid
    Dosage: 65 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-07

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Rituximab
    Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Solu-Medrol
    Dosage: 500 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-07

Abiplatin
    Dosage: 40 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-06

Other drugs received by patient: Ultracet; Vitamin B6; Chlorhexidine; Norvasc; Senokot; Aloxi

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017